Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2026 financial results ...
Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results